Drug regulator suspends licence for Pres Vu eye drop that …
WEBSep 11, 2024 · Entod's PresVu eye drop license suspended for misleading claims about treating presbyopia. General public being misled by Entod Pharmaceuticals, says Drug Controller General of India. Company to challenge order
Company challenges suspension of eye drops claiming to replace …
WEBSep 12, 2024 · Entod Pharmaceuticals denies making false claims about their new PresVu eye drops and plans to challenge the suspension by the Drugs Controller General of India of its manufacturing and sales permission in court.
PresVu eye drops: Why has a pharma company fallen in …
WEBPresVu eye drops, developed by Entod Pharmaceuticals, were launched with considerable media attention earlier this month as a novel solution for presbyopia. Presbyopia is a condition where...
Govt suspends license of PresVu wonder eye drops which claimed …
WEBSep 12, 2024 · The Drug Controller General of India has suspended the licence for PresVu, an eye drop by Entod Pharmaceuticals, due to unauthorised promotion. The eye drop claims to reduce the need for reading glasses in people with Presbyopia.
Why India's drug regulator has suspended licence for 'Pres
WEBSep 12, 2024 · The Drugs Controller General of India (DCGI) has suspended regulatory approval for PresVu, the eye drop that stirred excitement with its claim to replace reading glasses, before it could even hit retail shelves.
ENTOD Pharma appeals to DCGI over suspension, says PresVu eye …
WEB2 days ago · ENTOD Pharma met Drug Controller General of India (DCGI) officials earlier this week, and informed the regulator that PresVu eye drops were not intended to replace reading glasses, or non-invasive ...
PresVu Eye drops that could eliminate the need for reading …
WEBSep 3, 2024 · PresVu is claimed to be the first eye drop in India designed to reduce the need for reading glasses in people with presbyopia, a common age-related vision condition that affects people over 40. ENTOD Pharmaceuticals received final approval from the Drug Controller General of India.
Eye drops which claim to ‘reduce dependency on reading glasses’: …
WEBSep 9, 2024 · PresVu is a prescription-only medicine and, according to doctors, its impact is unlikely to last beyond four to six hours. It should not be used by people who have inflammation of the iris. Regular use of PresVu may lead to itching and redness, eyebrow pain, and muscle spasms in the eyes.
Drug regulator suspends product PresVu over unauthorised …
WEBThe Drugs Controller General of India (DCGI) on Wednesday suspended the product PresVu produced by Entod Pharmaceuticals after the company failed to respond to the queries on the product for...
Govt Suspends Licence Of PresVu Eyedrop Which Claimed To …
WEBSep 12, 2024 · The licence of PresVu eye drops, manufactured by Entod Pharmaceuticals, was suspended due to the company’s unauthorized promotions, creating doubts about the product's safety and its misuse by patients.